Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Paolo Lissoni. (1995) Section Review: Oncologic, Endocrine & Metabolic: Immunoneuroendocrine therapy for endocrine tumours: recent developments. Expert Opinion on Investigational Drugs 4:12, pages 1267-1272.
Read now
Read now
Articles from other publishers (45)
Basma Haris, Saras Saraswathi & Khalid Hussain. (2020) Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia. Therapeutic Advances in Endocrinology and Metabolism 11, pages 204201882096506.
Crossref
Crossref
Pradeep Kumar Siddappa & Santhi Swaroop Vege. (2019) Vasoactive Intestinal Peptide–Secreting Tumors. Pancreas 48:9, pages 1119-1125.
Crossref
Crossref
R. Arnold, P. Langer, Matthias Rothmund, G. Klöppel, P.H. Kann, J.T. Heverhagen, V. Fendrich, D.K. Bartsch, A. Rinke, X. Müller, K.J. Klose, W. Brenner, V. Prasad, B. Wiedenmann, H. Jann, T. Gress, A. Pascher, P. Neuhaus, N. Habbe, B. Simon & B. Stinner. 2013. Praxis der Viszeralchirurgie. Praxis der Viszeralchirurgie
497
628
.
Fernando Cirillo. (2018) Role of Somatostatin Analogs in the Management of Neuroendocrine Tumors. Tumori Journal 96:2, pages 191-197.
Crossref
Crossref
Marc J. Berna, K. Martin Hoffmann, Jose Serrano, Fathia Gibril & Robert T. Jensen. (2006) Serum Gastrin in Zollinger-Ellison Syndrome. Medicine 85:6, pages 295-330.
Crossref
Crossref
Gen-You Yao. (2003) Neuroendocrine markers in adenocarcinomas: an investigation of 356 cases. World Journal of Gastroenterology 9:4, pages 858.
Crossref
Crossref
H. Ahlman, R. Arnold, H. D. Becker, J. Beyer, O. Kisker, G. Klöppel, K. J. Klose, U. Pies, H. D. Röher, R. Rothmund, S. Schneider, B. Simon, D. Simon, B. Stinner, M. Rothmund & R. K. Teichmann. 2000. Praxis der Viszeralchirurgie. Praxis der Viszeralchirurgie
445
553
.
Yejun Zhao & Marie L Foegh. (1997) Angiopeptin, a Somatostatin Analogue, Inhibits Rat Coronary Artery and Aorta Smooth Muscle Cell Proliferation Induced by the Thromboxane A2 Mimetic U46619. Prostaglandins 54:5, pages 781-793.
Crossref
Crossref
Justin Geoghegan & Theodore N. Pappas. (1997) Clinical Uses of Gut Peptides. Annals of Surgery 225:2, pages 145-154.
Crossref
Crossref
Rudolf Arnold & Margareta Frank. (1996) Gastrointestinal endocrine tumours: Medical management. Baillière's Clinical Gastroenterology 10:4, pages 737-759.
Crossref
Crossref
Sarah Frankton & Stephen R. Bloom. (1996) Glucagonomas. Baillière's Clinical Gastroenterology 10:4, pages 697-705.
Crossref
Crossref
Sang Kyu Park, M. Sue O'Dorisio & Thomas M. O'Dorisio. (1996) Vasoactive intestinal polypeptide-secreting tumours: Biology and therapy. Baillière's Clinical Gastroenterology 10:4, pages 673-696.
Crossref
Crossref
F.A. Frizelle & M.V. Pfiefer. (1996) Paraneoplastic hypoglycaemia treated with somatostatin analogue SMS 201-995. European Journal of Surgical Oncology (EJSO) 22:5, pages 546-547.
Crossref
Crossref
Y. M. Liu. (1996) Development of labelled somatostatin and its analogues for the diagnosis and treatment of tumors. Journal of Radioanalytical and Nuclear Chemistry Articles 206:1, pages 171-184.
Crossref
Crossref
Sabahat Inanir, Mustafa �nl�, Berna Okudan, Erdal Cila & Sahap Atik. (1996) Indium-111 octreotide scintigraphy in patients with bone tumours of the extremities. European Journal of Nuclear Medicine 23:8, pages 987-990.
Crossref
Crossref
A. G. HARRIS & J. S. REDFERN. (2007) Octreotide treatment of carcinoid syndrome: analysis of published dose‐titration data. Alimentary Pharmacology & Therapeutics 9:4, pages 387-394.
Crossref
Crossref
Stefano Cascinu. (1995) Drug therapy in diarrheal diseases in oncology/hematology patients. Critical Reviews in Oncology/Hematology 18:1, pages 37-50.
Crossref
Crossref
B. MARK EVERS, JIN ISHIZUKA, COURTNEY M. TOWNSEND & JAMES C. THOMPSON. (1994) The Human Carcinoid Cell Line, BON.. Annals of the New York Academy of Sciences 733:1 Molecular and, pages 393-406.
Crossref
Crossref
Jens Juul Holst & Peter Schmidt. (1994) 6 Gut hormones and intestinal function. Baillière's Clinical Endocrinology and Metabolism 8:1, pages 137-164.
Crossref
Crossref
F. Jockenhövel, S. Lederbogen, T. Olbricht, H. Schmidt-Gayk, E. P. Krenning, S. W. J. Lamberts & D. Reinwein. (1994) The long-acting somatostatin analogue octreotide alleviates symptoms by reducing posttranslational conversion of prepro-glucagon to glucagon in a patient with malignant glucagonoma, but does not prevent tumor growth. Journal of Molecular Medicine 72:2, pages 127-133.
Crossref
Crossref
D. Wynick & S.R. Bloom. 1993. Surgical Endocrinology. Surgical Endocrinology
487
493
.
T. S. Gaginella. 1993. Gastrointestinal Regulatory Peptides. Gastrointestinal Regulatory Peptides
417
438
.
J. V. Anderson, S. Catnach, D. G. Lowe, P. D. Fairclough, G. M. Besser & J. A. H. Wass. (2008) Prevalence of gastritis in patients with acromegaly: untreated and during treatment with octreotide. Clinical Endocrinology 37:3, pages 227-232.
Crossref
Crossref
G. Schürmann, U. Raeth, W. Böhme, B. Wiedemann, H. Bihl & H. Buhr. 1992. Chirurgisches Forum ’92 für experimentelle und klinische Forschung. Chirurgisches Forum ’92 für experimentelle und klinische Forschung
1
4
.
P Diem & RP Robertson. (1991) Preventive effects of octreotide (SMS 201-995) on diabetic ketogenesis during insulin withdrawal.. British Journal of Clinical Pharmacology 32:5, pages 563-567.
Crossref
Crossref
G. Frost & S. Gilbey. (1991) Nutritional support in carcinoid tumour—a case study. Journal of Human Nutrition and Dietetics 4:5, pages 347-350.
Crossref
Crossref
B.Mark Evers, Courtney M. TownsendJr.Jr., J.Robert Upp, Erick Allen, Stephen C. Hurlbut, Sun Whe Kim, Srinivasan Rajaraman, Pomila Singh, Jean Claude Reubi & James C. Thompson. (1991) Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth. Gastroenterology 101:2, pages 303-311.
Crossref
Crossref
Michael S. Hickey. (1991) Nutritional Support of Patients with AIDS. Surgical Clinics of North America 71:3, pages 645-664.
Crossref
Crossref
Chen Peihui, Gustavo Baretton & Udo Löhrs. (1991) Immunocytochemical study of enterochromaffin cells in carcinomas of the large intestine. Chinese Journal of Cancer Research 3:2, pages 45-49.
Crossref
Crossref
T.S. Gaginella, T.M. O'Dorisio, J.E. Fassler & H.S. Mekhjian. (1990) Treatment of endocrine and nonendocrine secretory diarrheal states with Sandostatin®. Metabolism 39:9, pages 172-175.
Crossref
Crossref
C. MAHLER, J. VERHELST, M. DE LONGUEVILLE & A. HARRIS. (2008) LONG‐TERM TREATMENT OF METASTATIC MEDULLARY THYROID CARCINOMA WITH THE SOMATOSTATIN ANALOGUE OCTREOTIDE. Clinical Endocrinology 33:2, pages 261-269.
Crossref
Crossref
Steven W.J. Lamberts, Eric P. Krenning, Jan G.M. Klijn & Jean-Claude Reubi. (1990) 2 The clinical use of somatostatin analogues in the treatment of cancer. Baillière's Clinical Endocrinology and Metabolism 4:1, pages 29-49.
Crossref
Crossref
Paul N. Maton. (1989) The Use of the Long-Acting Somatostatin Analogue, Octreotide Acetate, in Patients with Islet Cell Tumors. Gastroenterology Clinics of North America 18:4, pages 897-922.
Crossref
Crossref
Thomas M. O’Dorisio, Hagop S. Mekhjian & T.S. Gaginella. (1989) Medical Therapy of VIPomas. Endocrinology and Metabolism Clinics of North America 18:2, pages 545-556.
Crossref
Crossref
Walter Londong, Michael Angerer, Klaus Kutz, Ruediger Landgraf & Vera Londong. (1989) Diminishing efficacy of octreotide (SMS 201-995) on gastric functions of healthy subjects during one-week administration. Gastroenterology 96:3, pages 713-722.
Crossref
Crossref
Paul N. Maton, Jerry D. Gardner & Robert T. Jensen. (1989) Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors. Digestive Diseases and Sciences 34:S3, pages S28-S39.
Crossref
Crossref
Walter Londong, Michael Angerer, Klaus Kutz, Ruediger Landgraf & Vera Londong. (1989) Diminishing Efficacy of Octreotide (SMS 201-995) on Gastric Functions of Healthy Subjects During One-Week Administration. Gastroenterology 96:2, pages 713-722.
Crossref
Crossref
Plinio Rossi, David J. Allison, Mario Bezzi, Anne Kennedy, Francesca Maccioni, David Wynick, Amelia Maradei & Steven R. Bloom. (1989) Endocrine Tumors of the Pancreas. Radiologic Clinics of North America 27:1, pages 129-161.
Crossref
Crossref
D. Wynick, J.M. Polak & S.R. Bloom. (1989) Somatostatin and its analogues in the therapy of gastrointestinal disease. Pharmacology & Therapeutics 41:1-2, pages 353-370.
Crossref
Crossref
T. S. Gaginella, T. M. O’Dorisio, H. S. Mekhjian, M. S. O’Dorisio & E. A. Woltering. 1989. Sandostatin® in the Treatment of Gastroenteropancreatic Endocrine Tumors. Sandostatin® in the Treatment of Gastroenteropancreatic Endocrine Tumors
23
38
.
Jack M. Rosenberg. (1988) Octreotide: A Synthetic Analog of Somatostatin. Drug Intelligence & Clinical Pharmacy 22:10, pages 748-754.
Crossref
Crossref
David Wynick, Susan J. Williams & Stephen R. Bloom. (1988) Symptomatic Secondary Hormone Syndromes in Patients with Established Malignant Pancreatic Endocrine Tumors. New England Journal of Medicine 319:10, pages 605-607.
Crossref
Crossref
Frederick J. Rescorla, Dennis W. Vane, Joseph F. Fitzgerald, Karen W. West & Jay L. Grosfeld. (1988) Vasoactive intestinal polypeptide-secreting ganglioneuromatosis affecting the entire colon and rectum. Journal of Pediatric Surgery 23:7, pages 635-637.
Crossref
Crossref
S. W. J. LAMBERTS, J. W. KOPER & J. ‐C. REUBI. (2008) Potential role of somatostatin analogues in the treatment of cancer. European Journal of Clinical Investigation 17:4, pages 281-287.
Crossref
Crossref
J.V. Anderson & S.R. Bloom. (1987) TREATMENT OF MALIGNANT ENDOCRINE PANCREATIC TUMOURS WITH HUMAN LEUCOCYTE INTERFERON. The Lancet 329:8524, pages 97.
Crossref
Crossref